Accession Number: | 0001209191-20-040662 |
Date: | 2020-07-01 |
Issuer: | VIR BIOTECHNOLOGY, INC. (VIR) |
Original Submission Date: |
PANG PHILLIP
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO, CA 94158
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-01 | M | 2,778 | a | $1.58 | 18,555 | direct | ||
COMMON STOCK | 2020-07-01 | M | 9,722 | a | $5.18 | 28,277 | direct | ||
COMMON STOCK | 2020-07-01 | S | 7,500 | d | $37.79 | 23,277 | direct | ||
COMMON STOCK | 2020-07-01 | S | 5,000 | d | $37.77 | 15,777 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 1.575 | 2020-07-01 | deemed execution date | M | 2,778 (d) | 2028-07-19 | common stock 2,778 | $1.58 | 108,333 | direct | ||
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 5.175 | 2020-07-01 | deemed execution date | M | 9,722 (d) | 2029-03-11 | common stock 9,722 | $5.18 | 76,338 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 14, 2020. |
f2 | 1/4 of the shares subject to the stock option vested and became exercisable on july 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |
f3 | 1/4 of the shares subject to the stock option vested and became exercisable on march 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter. |